Journal of Dental Anesthesia and Pain Medicine

The Korean Dental Society of Anesthsiology (대한치과마취과학회)
권호 표지
DOI QR코드

DOI QR Code

Analysis of the effect of fentanyl dosage used in patient-controlled analgesia for pain management after oral cancer surgery: a retrospective observational study

  • Kyung Nam Park (Department of Dental Anesthesiology, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Seung-Hwa Ryoo (Department of Dental Anesthesiology, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Myong-Hwan Karm (Department of Dental Anesthesiology, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Hyun Jeong Kim (Department of Dental Anesthesiology, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Kwang-Suk Seo (Department of Dental Anesthesiology, School of Dentistry and Dental Research Institute, Seoul National University)
  • Received : 2024.12.12
  • Accepted : 2025.01.17
  • Published : 2025.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Postoperative pain management is challenging in patients with oral cancer, especially those undergoing reconstructive surgery. Patient-controlled analgesia (PCA) is widely used, and fentanyl (FTN) concentration adjustments may improve pain control. This study aimed to evaluate the effects of FTN PCA concentration and reconstructive surgery on postoperative pain in patients with oral cancer. Methods: This retrospective observational study analyzed 140 patients with oral cancer who underwent surgery under general anesthesia. Patients were categorized based on FTN PCA dosage (FTN 700 mcg and ketorolac 150 mg vs. FTN 1400 mcg and ketorolac 150 mg). Pain was assessed using the visual analog scale (VAS) at multiple time points postoperatively (0, 12, 24, 36, 48, 60, and 72 h). PCA usage patterns, including demand count, delivery count, and delivery/demand ratios, were compared across subgroups. Missing data were imputed using linear interpolation. Results: PCA usage and pain control were evaluated between the FTN 700 mcg (N = 40) and 1400 mcg (N = 100) groups, stratified by reconstruction status. Demographic characteristics showed no significant difference. In the reconstructive surgery subgroup, patients in the FTN 1400 mcg group showed lower PCA refill counts (1.45 ± 0.69 vs. 1.61 ± 0.58) and fewer delivery counts (17.1 ± 21.3 vs. 25.1 ± 28.5) compared to those in the FTN 700 mcg group, achieving similar or superior pain control with fewer interventions. Similarly, patients without reconstructive surgery in the FTN 1400 mcg group demonstrated lower PCA refill counts, shorter PCA usage times, and fewer delivery counts. VAS scores decreased consistently over time across all groups but remained higher in the reconstruction groups. Logistic regression analysis revealed that patients with reconstructive surgery in the FTN 1400 mcg group were more likely to achieve a VAS score of ≤ 3.0 at 72 h postoperatively (P = 0.022). These findings indicate FTN 1400 mcg's superiority in managing postoperative pain. Conclusion: Comparing FTN PCA dosages, 1400 mcg demonstrated superior pain control to 700 mcg in patients undergoing oral cancer surgery, particularly those who underwent reconstructive surgery. This finding underscores the importance of optimizing FTN dosages to enhance postoperative pain management, reduce PCA-related demands, and achieve better patient outcomes.

Keywords

References

  1. Sjamsudin E, Maulina T, Cipta A, Iskandarsyah A, Hardianto A, Nandini M, et al. Assessment of oral cancer pain, anxiety, and quality of life of oral squamous cell carcinoma patients with invasive treatment procedure. Oral Maxillofac Surg 2018; 22: 83-90. https://doi.org/10.1007/s10006-018-0672-3
  2. Harada Y, Ihara Y, Tamai T, Ishiguro M, Tashimo Y, Nozue S, et al. Left-right differences in oral function and quality of life of patients who underwent tongue resection. Cureus 2024; 16: e71831. https://doi.org/10.7759/cureus.71831
  3. Yang Y, Zhang P, Li W. Comparison of orofacial pain of patients with different stages of precancer and oral cancer. Sci Rep 2017; 7: 203. https://doi.org/10.1038/s41598-017-00370-x
  4. Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, et al. Measuring head and neck cancer symptom burden: the development and validation of the M.D. Anderson symptom inventory, head and neck module. Head Neck 2007; 29: 923-31. https://doi.org/10.1002/hed.20602
  5. Shen YC, Liao KL, Cheng KI, Tseng KY, Su MP. Persistent postsurgical pain in oral cancer patients reconstructed with anterolateral thigh free flap. Medicina (Kaunas) 2022; 58:391. https://doi.org/10.3390/medicina58030391
  6. Vu CN, Lewis CM, Bailard NS, Kapoor R, Rubin ML, Zheng G. Association between multimodal analgesia administration and perioperative opioid requirements in patients undergoing head and neck surgery with free flap reconstruction. JAMA Otolaryngol Head Neck Surg 2020; 146: 708-13. https://doi.org/10.1001/jamaoto.2020.1170
  7. Go BC, Go CC, Chorath K, Moreira A, Rajasekaran K. Multimodal analgesia in head and neck free flap reconstruction: a systematic review. Otolaryngol Head Neck Surg 2022; 166: 820-31. https://doi.org/10.1177/01945998211032910
  8. Dort JC, Farwell DG, Findlay M, Huber GF, Kerr P, Shea-Budgell MA, et al. Optimal perioperative care in major head and neck cancer surgery with free flap reconstruction: a consensus review and recommendations from the enhanced recovery after surgery society. JAMA Otolaryngol Head Neck Surg 2017; 143: 292-303. https://doi.org/10.1001/jamaoto.2016.2981
  9. Eggerstedt M, Stenson KM, Ramirez EA, Kuhar HN, Jandali DB, Vaughan D, et al. Association of perioperative opioid-sparing multimodal analgesia with narcotic use and pain control after head and neck free flap reconstruction. JAMA Facial Plast Surg 2019; 21: 446-51. https://doi.org/10.1001/jamafacial.2019.0612
  10. Inchingolo AM, Dipalma G, Inchingolo AD, Palumbo I, Guglielmo M, Morolla R, et al. Advancing postoperative pain management in oral cancer patients: a systematic review. Pharmaceuticals (Basel) 2024; 17: 542. https://doi.org/10.3390/ph17040542
  11. Van Abel KM, Sauer AB, Kruthiventi SC, Weingarten TN, Noel DB, Price DL, et al. Non-opioid analgesics and post-operative pain following transoral robotic surgery for oropharyngeal cancer. J Laryngol Otol 2022; 136: 527-34. https://doi.org/10.1017/S0022215121004734
  12. Tartar QA, Park KN, Seo KS, Karm MH. Surgical frequency analysis of patients clustered according to postoperative pain trajectory: a retrospective study. Sci Rep 2025; 15: 809. https://doi.org/10.1038/s41598-024-83843-0
  13. Go BC, Go CC, Chorath K, Moreira A, Rajasekaran K. Nonopioid perioperative analgesia in head and neck cancer surgery: a systematic review. World J Otorhinolaryngol Head Neck Surg 2022; 8: 107-17. https://doi.org/10.1002/wjo2.62
  14. Mastrolonardo EV, Mann DS, Sethi HK, Yun BH, Sina EM, Armache M, et al. Perioperative opioids and survival outcomes in resectable head and neck cancer: a systematic review. Cancer Med 2023; 12: 18882-8. https://doi.org/10.1002/cam4.6524
  15. Kuo IT, Chang KY, Juan DF, Hsu SJ, Chan CT, Tsou MY. Time-dependent analysis of dosage delivery information for patient-controlled analgesia services. PLoS One 2018; 13: e0194140. https://doi.org/10.1371/journal.pone.0194140
  16. Peng Z, Zhang Y, Guo J, Guo X, Feng Z. Patient-controlled intravenous analgesia for advanced cancer patients with pain: a retrospective series study. Pain Res Manag 2018; 2018: 7323581. https://doi.org/10.1155/2018/7323581
  17. Schiessl C, Schestag I, Sittl R, Drake R, Zernikow B. Rhythmic pattern of pca opioid demand in adults with cancer pain. Eur J Pain 2010; 14: 372-9. https://doi.org/10.1016/j.ejpain.2009.06.009
  18. Chang KY, Tsou MY, Chan KH, Sung CS, Chang WK. Factors affecting patient-controlled analgesia requirements. J Formos Med Assoc 2006; 105: 918-25. https://doi.org/10.1016/S0929-6646(09)60177-7
  19. Lin SP, Chang KY, Tsou MY, Chen TH. Serial analgesic consumptions and predictors of intravenous patient-controlled analgesia with cluster analysis. Clin J Pain 2016; 32: 488-94. https://doi.org/10.1097/AJP.0000000000000312
  20. Park S, Chi SI, Seo KS, Kim HJ. Circadian variation of iv pca use in patients after orthognathic surgery - a retrospective comparative study. J Dent Anesth Pain Med 2015; 15: 141-6. https://doi.org/10.17245/jdapm.2015.15.3.141
  21. Cicekci F, Sargin M, Siki FO. How does circadian rhythm affect postoperative pain after pediatric acute appendicitis surgery? Anesth Pain Med (Seoul) 2024; 19: 125-33. https://doi.org/10.17085/apm.23038
  22. Chen SC, Liao CT, Chang JT. Orofacial pain and predictors in oral squamous cell carcinoma patients receiving treatment. Oral Oncol 2011; 47: 131-5. https://doi.org/10.1016/j.oraloncology.2010.11.004
  23. Malamed SF. Pain management following dental trauma and surgical procedures. Dent Traumatol 2023; 39: 295-303. https://doi.org/10.1111/edt.12840
  24. Pang J, Tringale KR, Tapia VJ, Moss WJ, May ME, Furnish T, et al. Chronic opioid use following surgery for oral cavity cancer. JAMA Otolaryngol Head Neck Surg 2017; 143: 1187-94. https://doi.org/10.1001/jamaoto.2017.0582
  25. Devine EC, Bevsek SA, Brubakken K, Johnson BP, Ryan P, Sliefert MK, et al. AHCPR clinical practice guideline on surgical pain management: adoption and outcomes. Res Nurs Health 1999; 22: 119-30. https://doi.org/10.1002/(SICI)1098-240X(199904)22:2<119::AID-NUR4>3.0.CO;2-W
  26. Alamir AH, Patil S. Allicin could potentially alleviate oral cancer pain by inhibiting "pain mediators" TNF-alpha, IL-8, and endothelin. Curr Issues Mol Biol 2021; 43: 187-96. https://doi.org/10.3390/cimb43010016
  27. Ou M, Wang G, Yan Y, Chen H, Xu X. Perioperative symptom burden and its influencing factors in patients with oral cancer: a longitudinal study. Asia Pac J Oncol Nurs 2022; 9: 100073. https://doi.org/10.1016/j.apjon.2022.100073
  28. Park I, Hong S, Kim SY, Hwang JW, Do SH, Na HS. Reduced side effects and improved pain management by continuous ketorolac infusion with patient-controlled fentanyl injection compared with single fentanyl administration in pelviscopic gynecologic surgery: a randomized, double-blind, controlled study. Korean J Anesthesiol 2024; 77: 77-84. https://doi.org/10.4097/kja.23217
  29. Bobian M, Gupta A, Graboyes EM. Acute pain management following head and neck surgery. Otolaryngol Clin North Am 2020; 53: 753-64. https://doi.org/10.1016/j.otc.2020.05.005